A detailed history of Prospera Financial Services Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Prospera Financial Services Inc holds 72,554 shares of ABBV stock, worth $13.1 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
72,554
Previous 71,848 0.98%
Holding current value
$13.1 Million
Previous $12.3 Million 16.26%
% of portfolio
0.37%
Previous 0.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$163.84 - $199.33 $115,671 - $140,726
706 Added 0.98%
72,554 $14.3 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $1.84 Million - $2.15 Million
11,884 Added 19.82%
71,848 $12.3 Million
Q1 2024

Aug 13, 2024

SELL
$159.82 - $182.1 $809,008 - $921,790
-5,062 Reduced 7.05%
66,786 $12.2 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $423,395 - $476,842
3,077 Added 5.41%
59,964 $9.29 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $21,240 - $24,589
159 Added 0.28%
56,887 $8.48 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $1.14 Million - $1.42 Million
8,632 Added 17.95%
56,728 $7.64 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $213,444 - $245,813
1,476 Added 3.17%
48,096 $7.67 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $1.33 Million - $1.6 Million
9,622 Added 26.01%
46,620 $7.54 Million
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $1.01 Million - $1.16 Million
7,553 Added 25.65%
36,998 $4.97 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $252,119 - $320,526
-1,832 Reduced 5.86%
29,445 $4.52 Million
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $7.94 Million - $9.86 Million
-60,198 Reduced 65.81%
31,277 $5.08 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $484,509 - $613,044
4,510 Added 5.19%
91,475 $12.4 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $582,752 - $661,512
5,477 Added 6.72%
86,965 $9.38 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $5.84 Million - $6.5 Million
55,461 Added 213.09%
81,488 $9.18 Million
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $204,497 - $225,127
1,999 Added 8.32%
26,027 $2.82 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $1.92 Million - $2.59 Million
23,850 Added 13398.88%
24,028 $2.58 Million
Q3 2020

Nov 04, 2020

SELL
$85.91 - $100.83 $2.27 Million - $2.66 Million
-26,385 Reduced 99.33%
178 $16,000
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $345,572 - $462,427
4,710 Added 21.55%
26,563 $2.6 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $25,284 - $38,333
392 Added 1.83%
21,853 $1.67 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $107,690 - $134,743
1,493 Added 7.48%
21,461 $1.9 Million
Q3 2019

Oct 22, 2019

BUY
$62.98 - $75.72 $278,497 - $334,833
4,422 Added 28.44%
19,968 $1.51 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $223,445 - $285,615
-3,401 Reduced 19.33%
14,192 $1.3 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $88,957 - $113,708
1,354 Added 9.54%
15,546 $1.13 Million
Q1 2019

May 02, 2019

BUY
$77.14 - $90.79 $262,353 - $308,776
3,401 Added 23.96%
17,593 $1.48 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $1.53 Million - $1.89 Million
-19,689 Reduced 58.11%
14,192 $1.3 Million
Q3 2018

Oct 25, 2018

SELL
$88.91 - $98.84 $3.81 Million - $4.23 Million
-42,842 Reduced 55.84%
33,881 $3.17 Million
Q2 2018

Jul 18, 2018

SELL
$89.78 - $106.23 $115,816 - $137,036
-1,290 Reduced 1.65%
76,723 $7.2 Million
Q1 2018

Apr 12, 2018

SELL
$92.01 - $123.21 $786,041 - $1.05 Million
-8,543 Reduced 9.87%
78,013 $7.3 Million
Q4 2017

Jan 24, 2018

SELL
$89.56 - $98.21 $431,589 - $473,273
-4,819 Reduced 5.27%
86,556 $8.52 Million
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $6.38 Million - $8.15 Million
91,375
91,375 $8.19 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.